appetite; vagus; fundus; stomach; medulla GHRELIN IS A RECENTLY IDENTIFIED endogenous ligand for growth hormone secretagogue receptor (GHS-R) and was originally isolated from the stomach (19). In addition to GH-releasing activity, ghrelin has an orexigenic (appetite-enhancing) effect. This is very reasonable, since the blood ghrelin level rose sharply just before onset of the dark phase, and the stomach ghrelin level was high during fasting in rats (30). Ghrelin has been shown to be present not only in the stomach but also in the hypothalamus, and it participates in the regulation of food intake itself and feeding-related phenomena through the peripheral and central nervous system (5, 25). Since feeding is closely related to digestive function, the effects of orexigenic peptides on gastric acid secretion, bile secretion, and gastric motility have been well investigated (3, 10, 15, 18, 20, 24, 29, 35) . Orexigenic peptides generally stimulate gastric acid secretion (23, 24, 33) and phasic contractions of the distal stomach (3, 15, 20, 23) , which enhance the ability to churn the gastric contents to accelerate gastric emptying; these gastric functions are particularly important for digestion. Accommodation of food is also important for smooth digestion, and impaired accommodation is thought to be one of the factors inducing meal-related symptoms, such as functional dyspepsia (31). The proximal region of the stomach, which serves as a reservoir, relaxes to accommodate food and fluid during swallowing (2, 17). Our previous studies revealed that fourth ventricular administration (and/or intramedullary injections) of orexin-A and neuropeptide Y (NPY), which are well-known orexigenic peptides, induced relaxation of the proximal stomach to facilitate the reservoir function of the stomach (15, 18).
GHRELIN IS A RECENTLY IDENTIFIED endogenous ligand for growth hormone secretagogue receptor (GHS-R) and was originally isolated from the stomach (19) . In addition to GH-releasing activity, ghrelin has an orexigenic (appetite-enhancing) effect. This is very reasonable, since the blood ghrelin level rose sharply just before onset of the dark phase, and the stomach ghrelin level was high during fasting in rats (30) . Ghrelin has been shown to be present not only in the stomach but also in the hypothalamus, and it participates in the regulation of food intake itself and feeding-related phenomena through the peripheral and central nervous system (5, 25) . Since feeding is closely related to digestive function, the effects of orexigenic peptides on gastric acid secretion, bile secretion, and gastric motility have been well investigated (3, 10, 15, 18, 20, 24, 29, 35) . Orexigenic peptides generally stimulate gastric acid secretion (23, 24, 33) and phasic contractions of the distal stomach (3, 15, 20, 23) , which enhance the ability to churn the gastric contents to accelerate gastric emptying; these gastric functions are particularly important for digestion. Accommodation of food is also important for smooth digestion, and impaired accommodation is thought to be one of the factors inducing meal-related symptoms, such as functional dyspepsia (31) . The proximal region of the stomach, which serves as a reservoir, relaxes to accommodate food and fluid during swallowing (2, 17) . Our previous studies revealed that fourth ventricular administration (and/or intramedullary injections) of orexin-A and neuropeptide Y (NPY), which are well-known orexigenic peptides, induced relaxation of the proximal stomach to facilitate the reservoir function of the stomach (15, 18) .
Ghrelin, as well as other orexigenic peptides, controls gastric functions. Intravenous administration of ghrelin stimulates gastric acid secretion and gastric motility in rats (23) . Central and peripheral administration of ghrelin induced fasted motor activity of the gastrointestinal tract in rats (8) . Histological study confirmed GHS-R mRNA expression in several hypothalamic nuclei, many of which have long been recognized as playing roles in body weight and food intake in rats and mice (37) . In addition, GHS-R mRNA has also been found in the dorsal vagal complex (DVC), including the area postrema (AP), nucleus of the solitary tract (NST) and dorsal motor nucleus of the vagus (DMV). Immunohistochemical study revealed that GHS-R was expressed in the NST and DMV in rats (22) . Microinjection of ghrelin into the DVC facilitated food intake (7) . Since the DVC is the center for controlling gastric motility, it is plausible that ghrelin induces relaxation of the proximal stomach, as well as other orexigenic peptides, as shown in our previous studies (15, 18) . Additionally, recent studies revealed that the intermediate and caudal DMV contain different groups of preganglionic neurons (21, 36) . It is well known that the caudal part of the DMV is involved in gastric relaxation (12, 18, 21, 36) . Microinjection of L-glutamate into the caudal DMV induced relaxation (21) . Microinjection of prolactinreleasing peptide into the caudal DMV induced gastric relaxation, although a similar injection into the rostral DMV increased intragastric pressure (12) . Our previous study also showed that microinjection of Y1 receptor agonist into the caudal DMV induced gastric relaxation (18) . Thus, the caudal DMV is intimately involved in gastric relaxation.
In the present study, we therefore examined the effect of ghrelin on motility of the proximal stomach in anesthetized rats. The effects of fourth ventricular administration of ghrelin on proximal stomach motility were investigated. Furthermore, the effect of the local administration of ghrelin was also investigated to demonstrate that the caudal DVC is responsible for relaxation of the proximal stomach induced by ghrelin.
MATERIALS AND METHODS

Animals, preparations, and recording of intragastric pressure.
Animal care was in accordance with the guidelines of the Physiological Society of Japan. The experimental protocols were approved by Okayama University Animal Use Committee.
Male Sprague-Dawley rats (280 -320 g) were used. Each animal was anesthetized with an intraperitoneal injection of urethane-chloralose (urethane, 0.8 g/kg; chloralose, 65 mg/kg body wt). Subsequent anesthesia was administered through Silastic tubing (OD: 1.0 mm, ID: 0.5 mm) inserted into the right jugular vein. Each animal had a tracheal cannula made from polyethylene tubing (OD: 2.07 mm). After an abdominal incision was made, gastric contents were gently squeezed out of the tip of the fundus, and the stomach was washed out twice using Ringer solution. A balloon, created from thin latex rubber and plastic tubing (OD: 1.7 mm) and another tube (OD: 2.0 mm) to drain gastric juices were introduced into the stomach (15) (16) (17) (18) . When recording proximal stomach motility, a balloon was introduced into the proximal stomach from the tip of the fundus. The balloon was secured by purse sutures around the gastric wall using 4 -0 silk thread. The plastic tubing protruding through the abdomen was ligated to the gastric wall around the tubing. Another tube was introduced into the stomach from the greater curvature just distal to the limiting ridge to drain gastric juices and was ligated to the gastric wall around the tubing. It was confirmed that the inflated balloon was correctly settled in the proximal part of the stomach. When recording distal stomach motility, a balloon was introduced into the distal stomach from the greater curvature just proximal to the limiting ridge toward the antrum. The balloon was secured by purse sutures around the gastric wall using 4 -0 silk thread. The plastic tubing protruding through the abdomen was ligated to the gastric wall around the tubing. Another tube was introduced into the fundus to drain gastric juices, and was ligated to the gastric wall around the tubing. It was confirmed that the inflated balloon was correctly settled in the distal part of the stomach.
After closing the abdominal incision, each animal was mounted on a stereotaxic apparatus. The neck muscles were removed and the ligaments between the occipital bone and atlas were carefully removed. A small hole was made through the dura mater to administer drugs using a Hamilton syringe into the fourth ventricle, as previously described (15, 18) . When the drugs were injected into the DVC using a glass micropipette, the occipital bone and dura mater were removed to expose the surface of the brain stem. Animals were placed in the prone position during the experiments. Body temperature was maintained at 36°C using a heating pad placed under the body (ATB-1100; Nihon Kohden, Tokyo, Japan).
The intragastric balloon was inflated with 0.2-0.5 ml water, maintaining initial intragastric pressure (IGP) of 0.5-0.7 kPa. A similar volume was used in our previous studies to measure gastric relaxation of the proximal stomach (15) (16) (17) (18) . After gastric balloon inflation, animals were left for at least 60 min until IGP stabilized. The distal end of this tubing was connected to a strain-gauge pressure meter (NEC-Sanei, 6M82; Tokyo, Japan) to measure IGP. Gastric response data were stored on a personal computer using the Power Lab system (ADInstruments, Colorado Springs, CO) for later analyses. At the end of each experiment, the abdomen was reopened, and the position of the balloon was confirmed again. The inflated balloon in each animal was always positioned in the correct part of the stomach.
Fourth ventricular administration of drugs. Dose-dependent relaxation of the proximal stomach and enhanced contractile activity of the distal stomach were studied with fourth ventricular administration of ghrelin. All drugs were dissolved in Ringer solution. Because we confirmed that similar administration of Ringer solution (3 l) did not induce any response of proximal and distal stomach motility in our previous study (15) , we did not test the effect of Ringer solution on motility in the present study. Four different ghrelin doses [1, 3, 10 , and 30 pmol (3 l)] for proximal stomach motility and four different ghrelin doses [3, 10, 30 , and 100 pmol (3 l)] for distal stomach motility were used. Each rat received at least three different doses of ghrelin. The gastric response was observed for at least 1 h after the administration of each drug. Drug doses were always administered in ascending order. The previous study showed that intracerebroventricular injection of ghrelin at doses of 10 pmol and above significantly increased food intake in rats (25) . Intracerebroventricular injection of 0.1 g (30 pmol) ghrelin stimulated antral motility in conscious rats (8) . Thus, the doses used in the present study are appropriate to investigate the phenomena associated with food intake, such as gastric motility.
To determine whether the ghrelin response is caused via growth hormone secretagogue receptor (GHS-R), the effects of [D-Lys 3 ] GHRP-6, which is a GHS-R antagonist, were tested. More than 1 h after observing the relaxation induced by the administration of ghrelin (10 pmol, 6 l), simultaneous administration of ghrelin (10 pmol, 3 l) and [D-Lys 3 ] GHRP-6 (1 nmol, 3 l) was performed using seven animals. Additionally, simultaneous administration of a higher dose of ghrelin (30 pmol, 3 l) and [D-Lys 3 ] GHRP-6 (1 nmol, 3 l) was performed using five animals. Further, it was confirmed using six rats that the administration of [D-Lys 3 ] GHRP-6 alone had no effect on proximal stomach motility. A dose of 1 nmol [D-Lys 3 ] GHRP-6 was sufficient to block the effect of the central injection of ghrelin on motor activity of the antrum, according to the previous study (8) .
Ghrelin was purchased from the Peptide Institute (Osaka, Japan). [D-Lys 3 ] GHRP-6 was purchased from Sigma-Aldrich (St. Louis, MO).
Cervical vagotomy. To determine the descending pathway, a vagotomy was performed in five rats. Both vagi were carefully separated from the left and right carotid arteries. After observing the relaxation induced by the administration of ghrelin (10 pmol, 3 m) into the fourth ventricle in the prone position, the solution was withdrawn from the balloon in the stomach. The animal was then turned to the supine position to section both vagi. After sectioning the vagi, the animal was placed in the prone position again, and the balloon was inflated again. More than 30 min after the vagotomy in each animal, the response to ghrelin (10 pmol, 3 m) was examined again in the prone position. Additionally, a higher dose of ghrelin (30 pmol, 3 l) was administered into the fourth ventricle using six additional animals, which preliminarily underwent bilateral cervical vagotomy.
We did not use artificial ventilation for bilateral vagotomized animals. Both vagotomies slowed the respiration phase and enlarged the magnitude of respiration; however, it was not fatal, at least during acute experiments. Bilateral cervical vagotomy has been used in other studies (17, 23) without artificial respiration using urethane-chloralose anesthetized rats.
In preliminary experiments using five animals, mean IGP tended to increase just after bilateral cervical vagotomy; however, it returned to normal 30 min after vagotomy. Mean intragastric pressure before the vagotomy was 0.68 Ϯ 0.05 kPa and that just after vagotomy was 0.83 Ϯ 0.11 kPa (t ϭ 1.59, NS compared with before the vagotomy). Mean intragastric pressure 30 min after vagotomy was 0.67 Ϯ 0.05 kPa; therefore, under our experimental conditions, it was not necessary to consider the effect of vagotomy on basal gastric tone itself.
Local administration of ghrelin. Commercially prepared glass micropipettes (10 m in tip diameter; World Precision Instruments, Sarasota, FL) connected to a 50-l Hamilton syringe were installed in a microinjector (XF-320J; Nihon Kohden, Japan) to inject ghrelin into the left DVC. Each glass pipette was first filled with fluid paraffin. The test solution was sucked into the tip of the pipette, which penetrated the caudal DVC or intermediate DVC at the left medulla using A stereotaxic apparatus. The coordinates were 0.3 mm posterior to the obex, 0.25 mm lateral to the midline, and 0.9 mm ventral from the surface of the brain stem for caudal DVC, and 0.5 mm anterior to the obex, 0.5 mm lateral to the midline, and 0.4 mm ventral from the surface of the brain stem for intermediate DVC. These locations corresponded with the boundary between the NST and the DMV, according to the atlas (27, 28) . Just after penetration, ghrelin (200 fmol, 60 nl) was injected for 30 s. Each 60-nl volume formed a sphere of about 500 m in diameter. The injection, therefore, filled the entire DMV and the adjacent NST and hypoglossal nucleus. To examine the effects of ghrelin, each animal received injections into either the caudal (6 rats) or intermediate (6 rats) part of the DVC. The stereotaxic coordinates, where the glass pipette penetrated, were identical to where we injected drugs in the previous study (18) . According to this previous study, dye injections into these areas stained the ventral part of the NST, DMV, and dorsal part of the hypoglossal nucleus. We also confirmed that injections of vehicle solution (60 nl of Ringer solution) into the caudal or intermediate part of the DVC induced no significant change in intragastric pressure; therefore, in the present study, we did not attempt vehicle injection into the DVC. In addition, the dose response function of ghrelin was examined using 20 animals. One of 3 doses of ghrelin (0.2 fmol, 2.0 fmol, or 20 fmol) was administered into the caudal DVC in each animal. Each injected volume was 60 nl, the same as the other injections.
In the present study, the part of the DVC located caudal to the obex was defined as the "caudal DVC," and the portion of the DVC located between the obex and anterior tip of the AP was defined as the "intermediate DVC," according to a previous study (Fig. 4C) (36) .
Data analyses. To analyze relaxation of the proximal stomach, the minimum value (kPa) was measured once every minute from 10 min before drug administration to 90 min after drug administration using chart software (AD Instruments). To analyze the contractile response of the distal stomach, the area under the contraction wave (kPa ϫ min) above minimum IGP in a 1-min period was calculated every minute from 10 min before drug administration to 90 min after drug administration using chart software (AD Instruments). The area for the 1-min period was used for the index of motility (motility index, MI). This method is suitable for minimizing the inclusion of the area formed by the slow change of the baseline. This analysis method was similar to that used in our previous study (9, 15, 18) .
All numerical values are expressed as the means Ϯ SE. Most statistical analyses were made between prestimulus values and poststimulus values using the paired t-test (P Ͻ 0.05 for significance). For statistical evaluation of the effects of fourth ventricular administration of drugs on proximal and distal stomach motility, the paired t-test (P Ͻ 0.05 for significance) was used. Differences between the mean of the minimum values of the IGP (or the area for 1-min period) just before administration of the solutions and those 21-22 min after the administration were examined, since mean IGP of proximal stomach motility showed the minimum value 21-22 min after the administration of 30 pmol ghrelin. Dose-related effect of ghrelin was evaluated by repeated-measures ANOVA (P Ͻ 0.05 for significance). To evaluate the effects of microinjection of drugs on proximal stomach motility, the paired t-test (P Ͻ 0.05 for significance) was used. Differences were examined between the mean of the minimum values just before solution injection and that 9 -10 min after injection, since mean IGP of proximal stomach motility showed a minimum value at 9 -10 min after the injection of 200 fmol ghrelin. Student's t-test was used to examine the difference between postinjection values of the microinjection into the intermediate DVC and that into the caudal DVC, as shown in Fig. 4B , b.
RESULTS
Ghrelin induced relaxation of the proximal stomach and stimulated contractility of the distal stomach.
The effects of fourth ventricular administration of ghrelin on motility of the proximal and distal stomach were examined. Administration of ghrelin induced relaxation of the proximal stomach in a dosedependent manner (Fig. 1A, a) . Low-dose (1 pmol) administration of ghrelin did not induce a significant decrease in IGP (t ϭ 0.17, NS, n ϭ 5); however, the administration of 3 pmol (t ϭ 2.86, P Ͻ 0.05, n ϭ 7), 10 pmol (t ϭ 12.58, P Ͻ 0.05, n ϭ 7), and 30 pmol (t ϭ 4.11, P Ͻ 0.05, n ϭ 7) ghrelin induced a significant decrease in IGP (Fig. 1A, b) . The degree of relaxation depended on the dose of ghrelin. Dose-related effect of ghrelin was statistically proven using repeated-measures ANOVA [F(3,12) ϭ 4.14, P Ͻ 0.05, n ϭ 5] for five rats which received four doses of ghrelin. Distal stomach contractility was conversely stimulated in response to ghrelin administration (Fig. 1B, a) . A significant increase in the MI was observed after the administration of 100 pmol ghrelin (t ϭ 2.47, P Ͻ 0.05, n ϭ 8); however, the administration of 3 pmol (t ϭ 0.65 , NS, n ϭ 7), 10 pmol (t ϭ 0.81, NS, n ϭ 8), and 30 pmol (t ϭ 1.16, NS, n ϭ 0.28) ghrelin did not induce a significant change (Fig. 1B, b) . Dose-related effect of ghrelin was statistically proven using repeated-measures ANOVA [F(3,18) ϭ 3.73, P Ͻ 0.05, n ϭ 7] for seven rats that received four doses of ghrelin.
Ghrelin induced relaxation of the proximal stomach via GHS-R. To determine whether relaxation of the proximal stomach was caused by GHS-R, the effect of GHS-R antagonist ([D-Lys 3 ] GHRP-6) on ghrelin-induced relaxation was examined.
Before testing the antagonist, the effect of repeated administrations of ghrelin was examined. More than 90 min after the first administration of ghrelin (10 pmol) into the fourth ventricle, ghrelin (10 pmol) was administered a second time into each animal. First, the administration of ghrelin induced a significant reduction in IGP (0.092 Ϯ 0.016 kPa, t ϭ 5.76, P Ͻ 0.05, n ϭ 6). Second, the administration of ghrelin also induced a significant reduction in IGP (0.097 Ϯ 0.026 kPa, t ϭ 3.78, P Ͻ 0.05, n ϭ 6). Thus, repeated administration of 10 pmol ghrelin caused a reproducible result. ] GHRP-6 (0.677 Ϯ 0.018 kPa) was not significantly different (t ϭ 2.39, NS, n ϭ 6) from that after administration (0.653 Ϯ 0.020 kPa); however, the ghrelin response was abolished by administration of [D-Lys 3 ] GHRP-6. Each animal first received fourth ventricular administration of ghrelin (10 pmol), which caused a significant decrease in IGP (Fig. 2, A and B) (t ϭ 7.85, P Ͻ 0.05, n ϭ 7). More than 90 min after the first administration, simultaneous administration of ghrelin (10 pmol ] GHRP-6 did not induce a significant change in IGP (Fig. 2, A and B) (t ϭ 0.01, NS, n ϭ 7). Furthermore, using the other five animals, simultaneous administration of a higher dose of ghrelin (30 pmol) and [D-Lys 3 ] GHRP-6 (1 nmol) into the fourth ventricle was performed, which did not induce a significant change in IGP (Fig.  2B) (t ϭ 1.20, NS, n ϭ 5) .
Contribution of vagal efferent neurons. To examine the contribution of parasympathetic preganglionic neurons, the effect of bilateral cervical vagotomy on relaxation induced by the administration of ghrelin (10 pmol) was examined. Vagotomy abolished the relaxation induced by the administration of ghrelin into the fourth ventricle (Fig. 3) . The significant decrease in IGP observed before sectioning of the vagi (t ϭ 11.07, P Ͻ 0.05, n ϭ 5) was not observed after sectioning (t ϭ 1.50, NS, n ϭ 5) (Fig. 3) . Furthermore, the effect of a higher dose of ghrelin (30 pmol, 3 l) was examined in six additional animals, which preliminarily underwent bilateral cervical vagotomy.
The mean IGP before the administration of ghrelin (0.653 Ϯ 0.016 kPa) was not significantly different (t ϭ 1.60, NS, N ϭ 6) from that after administration (0.650 Ϯ 0.017 kPa) in vagotomized animals.
Contribution of the caudal DVC to induce proximal stomach relaxation. The effects of local administration of ghrelin into the left intermediate or left caudal DVC were examined. A schematic representation of the injection sites is shown in Fig.  4C . The injection of ghrelin (200 fmol) into the intermediate DVC did not change the IGP (Fig. 4A, a) . Mean IGP after the injection of ghrelin was not significantly different from that before the injection (t ϭ 2.16, NS, n ϭ 6) (Fig. 4A, b) . In contrast, injection of ghrelin (200 fmol) into the caudal DVC induced obvious relaxation (Fig. 4B, a) . Mean IGP after the injection of ghrelin was significantly lower than that before the injection (t ϭ 4.24, P Ͻ 0.05, n ϭ 6) (Fig. 4B, b) . Mean IGP after the administration of ghrelin into the caudal DVC was significantly lower than that into the intermediate DVC (t ϭ 2.39, P Ͻ 0.05, n ϭ 6) (Fig. 4B, b) .
Furthermore, the effects of microinjection of different doses of ghrelin into the caudal DVC were examined. Mean GHRP-6 for GHS-R than ghrelin (11, 34) .
The main purpose of the present study was to identify the control mechanism of reservoir functions; therefore, most experiments were devoted to proximal stomach motility. Previous studies have clarified that the intravenous or intracerebroventricular administration of ghrelin enhances distal stomach motility (8, 23) . We have also indicated that a similar response of the distal stomach was observed in our experimental condition. Although systemic administration of ghrelin accelerates gastric emptying (6, 14) , the simultaneous occurrence of enhanced distal stomach motility and proximal stomach relaxation must be critical to the functional outcome of accelerated gastric emptying. Because actual transit of food into the duodenum is necessary for relaxation of the pyloric sphincter, which coordinates with antral contraction during the emptying period (40 -60 min after feeding) (13) , temporal and precise analyses are required to know the effect of ghrelin on the actual transit of food into the duodenum.
Systemic administration of ghrelin stimulates distal stomach motility (8, 23) and gastric emptying (6, 14) . Peripheral and central actions of ghrelin on distal stomach motility are almost the same. A few studies have investigated the effect of systemic administration of ghrelin on proximal stomach motility. An electrophysiological study using deprived mice revealed that the peripheral administration of ghrelin reduced afferent signals from gastric tension receptors (26) . Signaling of the presence and amount of food in the stomach is reduced; that is, desensitization of mechanosensitive afferents reduces satiation and allows the stomach to receive a large amount of food. This neural response seems likely to cooperate with the effects of central ghrelin on the proximal stomach observed in the present study. In contrast, bath application of ghrelin agonists reduced electrical field stimulation-induced relaxation in fundic strips (6) . Intravenous administration of ghrelin increased proximal stomach tone in deprived humans (32) . Thus, the peripheral action of ghrelin does not necessarily correspond to the central action as to the reservoir functions. The species of subjects and/or feeding conditions might induce different results. More investigations are needed to resolve this problem.
The present study showed that microinjection of 200 fmol ghrelin (60 nl) into the caudal DVC induced marked relaxation of the proximal stomach. Although we could not determine whether ghrelin acted on just NST or DMV neurons, the caudal DVC is the most probable area inducing relaxation of the proximal stomach. Microinjections of a lower dose of ghrelin into the caudal DVC revealed that 2 fmol (60 nl of 33 nM solution) but not 0.2 fmol (60 nl of 3.3 nM solution) ghrelin induced a significant decrease in IGP of the proximal stomach. For electrophysiological analysis of hypothalamic neurons, 15 nM solution of ghrelin were used in the previous study (4) . Thus, the effective concentration of proximal stomach relaxation was not so different from the previous study.
It is widely assumed that peptides and proteins cannot pass through the blood-brain barrier. A recent study using mice showed the existence of a saturable transporter in the bloodto-brain direction, which recognizes human ghrelin but not mouse ghrelin (1) . Thus, the transportability of peripheral ghrelin into the CNS might depend on the structure of ghrelin. The AP, which is located just above the NTS, has a loose blood-brain barrier and senses substances in the blood. It is, therefore, possible that ghrelin affects AP neurons; however, immunohistochemical study revealed that GHS-R was not observed in AP neurons (22) . Taken together, it is still debatable whether circulating ghrelin directly acts on neurons in the medulla to induce gastric motor response. The possibility that peripheral ghrelin affected caudal DVC neurons cannot be rejected.
Perspective and Significance
The present study showed for the first time that central ghrelin induced gastric relaxation of the proximal stomach. The result strongly suggests that ghrelin facilitates accommodation by the stomach of a meal without increasing IGP. Our previous studies also demonstrated that central orexin-A and NPY induced proximal stomach relaxation (15, 18) . It is, therefore, hypothesized that anticipatory gastric relaxation to accommodate food might be a common characteristic of orexigenic neuropeptides. This shows new features of the role of orexigenic neuropeptides in autonomic regulation associated with food intake. Fasting is followed by feeding; therefore, gastric relaxation achieved by the actions of orexigenic neuropeptides, which are released by fasting, to enhance reservoir function of the stomach, is rational. Since impaired accommodation of the proximal stomach during and after ingestion of food may be accompanied by increased IGP and intense activation of a gastric mechanoreceptor, thus inducing pathological early satiation (31), orexigenic neuropeptides might be quite important to enable normal healthy satiation.
